Citramalic Acid

If you have nagging digestive symptoms, brain fog, or fatigue and your standard labs look normal, you may be looking for clues in the wrong place. Urinary citramalic acid is one of a handful of small organic acids that show up in pee and may carry information about what is happening inside your gut, far from where most routine tests look.

This is a research-level marker, not a settled clinical test. Used carefully, it can add a layer of insight to your gut health workup. Used alone, it cannot diagnose anything by itself.

What This Molecule Actually Is

Citramalic acid, also called citramalate, is a small organic molecule. Chemically, it is structurally related to malate (essentially malate with an added methyl group). Unlike malate, which is a step in the chain of reactions your cells use to turn food into energy (the citric acid cycle), citramalate itself is not part of that cycle. It is mainly involved in distinct microbial pathways, such as how some microbes build the amino acid isoleucine. Citramalate is not a protein, enzyme, or hormone. It is a metabolite, a chemical byproduct of metabolism.

Human cells appear to make very little citramalate on their own, though the extent of human production is not well characterized. The molecule was historically associated with yeasts and certain anaerobic bacteria (microbes that grow without oxygen), but it is also produced by aerobic and facultatively anaerobic organisms. Because of that primarily microbial origin, urinary citramalate is commonly used in functional medicine settings as a possible signal of gut imbalance, where yeast or unusual bacteria are producing chemicals your body absorbs and clears through urine.

Why It Might Matter for Your Gut

The connection between citramalate and gut microbes is the main reason this marker shows up on urinary organic acid panels. The idea is straightforward: if microbes in your gut are producing more citramalate than usual, some of it gets absorbed into your bloodstream and excreted in urine, where it can be measured.

Direct human studies measuring urinary citramalic acid in well-defined gut disease populations are limited. One analytical methods paper included citramalic acid in a panel of compounds proposed as potential dysbiosis markers for gas chromatography analysis, but this was a method validation study, not a clinical validation. No published clinical trial or guideline currently validates urinary citramalic acid as a diagnostic marker for gut dysbiosis.

Signals From Other Body Fluids

Most of the clearer evidence about citramalate comes from samples other than urine. Treat these findings as background context, not as direct claims about your urine result.

In a study of adults with early-stage amyotrophic lateral sclerosis (ALS), a nerve disease that affects the muscles people use to move, citramalate was elevated in both blood serum and muscle tissue compared with healthy controls. Citramalate was the metabolite that most clearly separated the ALS group from healthy controls across both samples. Researchers proposed it as a possible biomarker candidate worth following, while noting that the underlying biology is not yet worked out and that larger ALS metabolomics studies have pointed to other metabolites, such as hypoxanthine, inosine, and sphingomyelins, as more robust candidates.

In a study of adults with chronic gum disease, citramalic acid in gum-pocket fluid was one of several metabolites that differed from healthy controls. Combined with another marker, the pair classified people with periodontitis from healthy controls with an AUC of about 0.876, meaning the test correctly ranked a sick person above a healthy one about 88 times out of 100 random pairings. That was measured in gum fluid, not urine, and reflects local mouth biology more than gut activity.

Neither of these findings was measured in urine, and neither has been replicated as a clear-cut urinary signal. They tell you that citramalate is biologically interesting in humans. They do not tell you what a specific urine number means for your health.

Why a Single Reading Is Not Enough

Urinary organic acids can shift from day to day depending on what you eat, how hydrated you are, and whether your gut microbes are in their usual state. A single elevated citramalate value, in isolation, is not a diagnosis of anything.

Track this marker the way you would any exploratory data point. Get a baseline. If the value is unusual or you make changes to your diet, your gut protocols, or your antifungal or antibiotic exposure, a follow-up test some months later can show whether the number is moving. Because no published evidence supports specific retesting intervals for urinary citramalic acid, any cadence is a practical choice, not an evidence-based rule.

Because this is a research-level marker without standardized clinical cutpoints, your own trend over time is more useful to you than any single number on a single day.

What an Unusual Result Should Actually Make You Do

An unexpectedly high urinary citramalate does not stand alone. It is a prompt to widen the lens, not a verdict. Pair the result with other information that can confirm or refute a gut microbial story.

• Look at the rest of the organic acid panel: other markers on the same test are sometimes interpreted alongside citramalate. Keep in mind that arabinose and its related metabolite D-arabinitol have validated evidence only for invasive candidiasis in immunocompromised patients, not for the general concept of gut yeast overgrowth, and that 5-hydroxymethyl-2-furoic acid is actually a metabolite of dietary 5-hydroxymethylfurfural from heat-processed foods like coffee, dried fruit, and honey, not a yeast marker. Interpret these patterns with that context.
• Add a direct gut test: a comprehensive stool analysis or gut microbiome panel can directly identify yeast overgrowth, dysbiotic bacteria, or markers of gut inflammation, which is far more specific than an indirect urinary signal.
• Map your symptoms: persistent bloating, brain fog, sugar cravings, recurrent yeast infections, or stool changes line up with the gut microbial story citramalate is sometimes used to investigate.
• Consider a clinician who reads these panels often: functional medicine and integrative gastroenterology practitioners interpret organic acid panels regularly and can place your number in the context of the full picture.

When Results Can Be Misleading

Several factors can move a single urinary citramalate reading without telling you anything meaningful about your underlying biology.

• Collection technique: organic acid testing is usually done on a first morning urine or a 24-hour collection. Mixing collection types, drinking heavily before the sample, or letting urine sit at room temperature can distort small metabolite values.
• Recent diet: fermented foods, sugar-rich meals, and yeast-containing foods within 24 to 72 hours of the collection can shift microbial byproducts in unpredictable ways.
• Recent antifungals or antibiotics: these drugs can temporarily knock back the microbes that produce citramalate, lowering urinary levels in a way that may not reflect your steady-state biology.
• Assay differences: reference ranges for citramalate vary between labs because there are no universal clinical cutpoints. Comparing a value from one lab to a range from another can mislead you.

Because this marker sits at the research edge of clinical testing, treat your results as one data point in a larger investigation, not as a final answer about your gut.